Dimensional Fund Advisors LP Lowers Holdings in Integer Holdings Co. (NYSE:ITGR)

Dimensional Fund Advisors LP lowered its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 4.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,700,370 shares of the medical equipment provider's stock after selling 70,778 shares during the period. Dimensional Fund Advisors LP owned approximately 5.07% of Integer worth $225,336,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Loomis Sayles & Co. L P increased its stake in Integer by 3.8% during the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider's stock valued at $74,041,000 after purchasing an additional 20,688 shares in the last quarter. Congress Asset Management Co. increased its position in shares of Integer by 2.0% during the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after acquiring an additional 9,565 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Integer by 1.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider's stock worth $54,146,000 after acquiring an additional 4,559 shares during the last quarter. Lord Abbett & CO. LLC lifted its position in Integer by 3.5% in the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after acquiring an additional 9,754 shares in the last quarter. Finally, Tributary Capital Management LLC increased its holdings in shares of Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock worth $38,103,000 after purchasing an additional 2,289 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Performance

Integer stock traded down $1.65 during mid-day trading on Monday, reaching $121.76. 89,013 shares of the company traded hands, compared to its average volume of 344,433. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The firm's fifty day moving average is $119.58 and its two-hundred day moving average is $130.28. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The company has a market capitalization of $4.25 billion, a price-to-earnings ratio of 36.30, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. On average, equities research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

ITGR has been the topic of a number of research analyst reports. KeyCorp lowered their price target on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. StockNews.com downgraded Integer from a "hold" rating to a "sell" rating in a report on Friday. Raymond James lifted their price target on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday. Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday. Finally, Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $145.56.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.